Wikidata entity: Q412050
C₂₀H₃₂O₅ (P274)
Quantities
| P2067 | mass | 352.224974 |
| P3780 | active ingredient in | ... | Q48826255 (Flolan) | Flolan |
| P3780 | active ingredient in | ... | Q48829241 (Veletri) | Veletri |
| P233 | canonical SMILES | String | CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O | ??? |
| P373 | Commons category | String | Prostacyclin | ??? |
| P703 | found in taxon | ... | Q15978631 (Homo sapiens) | Homo sapiens |
| P527 | has part(s) | ... | Q556 (hydrogen) | hydrogen |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Prostacyclin2.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC(O)=O | ??? |
| P2175 | medical condition treated | ... | Q1128595 (pulmonary hypertension) | pulmonary hypertension |
| P2175 | medical condition treated | ... | Q7232210 (Portopulmonary hypertension) | Portopulmonary hypertension |
| P2175 | medical condition treated | ... | Q18554296 (chronic pulmonary heart disease) | chronic pulmonary heart disease |
| P2175 | medical condition treated | ... | Q18554794 (primary pulmonary hypertension) | primary pulmonary hypertension |
| P1748 | NCI Thesaurus ID | String | C61748 | ??? |
| P361 | part of | ... | Q21438653 (prostacyclin receptor activity) | prostacyclin receptor activity |
| P2959 | permanent duplicated item | ... | Q16685333 (???) | ??? |
| P129 | physically interacts with | ... | Q21120420 (Prostaglandin E receptor 1) | Prostaglandin E receptor 1 |
| P129 | physically interacts with | ... | Q21120422 (Prostaglandin E receptor 4) | Prostaglandin E receptor 4 |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q190016 (heparin) | heparin |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q411932 ((S)-duloxetine) | (S)-duloxetine |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q414462 (apixaban) | apixaban |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q420262 (rivaroxaban) | rivaroxaban |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q898407 (venlafaxine) | venlafaxine |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q1640947 (phenindione) | phenindione |
| P769 | significant drug interaction | ... | Q3563148 (vortioxetine) | vortioxetine |
| P769 | significant drug interaction | ... | Q27077698 (fondaparinux) | fondaparinux |
| P3364 | stereoisomer of | ... | Q26998032 (Prostacyclin (not favourable)) | Prostacyclin (not favourable) |
| P279 | subclass of | ... | Q134856 (carboxylic acid) | carboxylic acid |
| P279 | subclass of | ... | Q209717 (prostaglandins) | prostaglandins |
| P279 | subclass of | ... | Q50228868 (prostaglandins I) | prostaglandins I |
| P2868 | subject has role | ... | Q575890 (antihypertensive drug) | antihypertensive drug |
| P2868 | subject has role | ... | Q721432 (platelet aggregation inhibitors) | platelet aggregation inhibitors |
| P2868 | subject has role | ... | Q3333419 (primary metabolite) | primary metabolite |
Why not click here or view trends?
log id: 1968233